Clinical trial
Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1…
NCT00283387 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00283387 |
|---|---|
| Title | Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria |
| Official title | Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH Orphan Europe |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hyperoxaluria |
| Intervention type | Drug |
| Interventions | Betaine, Placebo |
| Enrollment | 15 |
| Start date | Feb 1, 2007 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Jan 27, 2006 |
| Last update posted | Dec 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: